Home > News > Content
Bladder Cancer Cells Chromosome And Gene Anomaly Probe
- Aug 15, 2018 -

DNA urine test can diagnose bladder cancer

A DNA-based urine test can detect genetic changes in bladder cells with almost twice the sensitivity of traditional urine cytology tests, which are used to initially diagnose bladder cancer in patients with hematuria (blood in the urine).

Bladder Cancer cells chromosome and gene anomaly probe

UroVysion is also considered a "molecular cytology test" because it can evaluate cell morphological changes and molecular level DNA changes in conventional cytology. It is designed to aid in the existing diagnostic process and to detect changes in chromosomes. This ability allows clinicians to gain a deeper understanding of tumor recurrence in patients who have been diagnosed with bladder cancer, in the initial diagnosis of hematuria patients. It is also more certain if you have bladder cancer.

According to a paper published in the July 2006 issue of the Journal of Urology, hematuria is the most common symptom of bladder cancer. However, because bladder cancer patients account for only about 10% of patients with hematuria, there is often a delay between the first symptom and diagnosis, which will adversely affect the patient's treatment.